Pharmacogenomics
A review of the existing pharmacogenomic literature of naltrexone for use in alcohol use disorder.
Christopher Counts, Nisha Ali, Syed Ali, Kafilah A Muhammad, Fatoumata B Diop, Keith Sims, Amarachukwu Ajoku, Cynthia Santos
Published: 202610.1080/14622416.2026.2613634
Abstract
Naltrexone is an opioid receptor antagonist used to treat alcohol use disorder; however, like other commonly used addiction treatment options, it demonstrates inconsistency in treatment response. Pharmacogenomics may be used to individualize addictio…
Preview only. Read the full abstract at the source